Introduction Levetiracetam (LEV) is a broad-spectrum antiepileptic that is recommended in the treatment of focal or generalized seizures.1 First approved by the Food and Drug Administration in 1999 and by Health Canada in 2003, it has since gained considerable popularity.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile